Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Number of holders
-
241
-
Total 13F shares, excl. options
-
275,685,202
-
Shares change
-
-1,395,891
-
Total reported value, excl. options
-
$2,723,386,669
-
Value change
-
-$230,544,914
-
Put/Call ratio
-
64.68%
-
Number of buys
-
137
-
Number of sells
-
-136
-
Price
-
$9.88
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q1 2021
343 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock as of Q1 2021.
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) has 241 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 275,685,202 shares
of 308,713,740 outstanding shares and own 89.3% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (24,387,053 shares), PERCEPTIVE ADVISORS LLC (22,861,329 shares), BlackRock Inc. (21,521,879 shares), Redmile Group, LLC (21,114,114 shares), WELLINGTON MANAGEMENT GROUP LLP (14,107,972 shares), Avoro Capital Advisors LLC (12,250,000 shares), JPMORGAN CHASE & CO (11,879,824 shares), MORGAN STANLEY (9,966,548 shares), Palo Alto Investors LP (9,761,043 shares), and STATE STREET CORP (9,536,942 shares).
This table shows the top 241 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.